polycystic kidney disease

Open Access
Changing Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Suzanne F. Ruff

CJASN June 2022, CJN.05790522; DOI: https://doi.org/10.2215/CJN.05790522

Add to Selected Citations
You have accessRestricted Access
Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging
Pedram Akbari, Fatemah Nasri, Shirley X. Deng, Saima Khowaja, Seung H. Lee, William Warnica, Hua Lu, Anand Rattansingh, Mostafa Atri, Korosh Khalili and Pei York

CJASN June 2022, 17 (6) 827-834; DOI: https://doi.org/10.2215/CJN.14931121

Add to Selected Citations
You have accessRestricted Access
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease
Kyongtae T. Bae, Cheng Tao, Robert Feldman, Alan S.L. Yu, Vicente E. Torres, Ronald D. Perrone, Arlene B. Chapman, Godela Brosnahan, Theodore I. Steinman, William E. Braun, Michal Mrug, William M. Bennett, Peter C. Harris, Avantika Srivastava, Douglas P. Landsittel, Kaleab Z. Abebe and the CRISP and HALT PKD Consortium

CJASN March 2022, 17 (3) 374-384; DOI: https://doi.org/10.2215/CJN.08660621

Add to Selected Citations
You have accessRestricted Access
Assessing Risk of Progression in ADPKD
Craig E. Gordon, Dana C. Miskulin and Ronald D. Perrone

CJASN January 2022, 17 (1) 134-136; DOI: https://doi.org/10.2215/CJN.13071021

Add to Selected Citations
Open Access
Overweight and Obesity and Progression of ADPKD
Kristen L. Nowak, Cortney Steele, Berenice Gitomer, Wenchyi Wang, John Ouyang and Michel B. Chonchol

CJASN June 2021, 16 (6) 908-915; DOI: https://doi.org/10.2215/CJN.16871020

Add to Selected Citations
Open Access
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies
Matthew B. Lanktree, Amirreza Haghighi, Ighli di Bari, Xuewen Song and York Pei

CJASN May 2021, 16 (5) 790-799; DOI: https://doi.org/10.2215/CJN.02320220

Add to Selected Citations
You have accessRestricted Access
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD
Matthew B. Lanktree, Elsa Guiard, Pedram Akbari, Marina Pourafkari, Ioan-Andrei Iliuta, Syed Ahmed, Amirreza Haghighi, Ning He, Xuewen Song, Andrew D. Paterson, Korosh Khalili and York P.C. Pei

CJASN March 2021, 16 (3) 374-383; DOI: https://doi.org/10.2215/CJN.11100720

Add to Selected Citations
You have accessRestricted Access
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement
Marie C. Hogan, Julie A. Chamberlin, Lisa E. Vaughan, Angela L. Waits, Carly Banks, Kathleen Leistikow, Troy Oftsie, Chuck Madsen, Marie Edwards, James Glockner, Walter K. Kremers, Peter C. Harris, Nicholas F. LaRusso, Vicente E. Torres and Tatyana V. Masyuk

CJASN September 2020, 15 (9) 1267-1278; DOI: https://doi.org/10.2215/CJN.13661119

Add to Selected Citations
You have accessRestricted Access
ADPKD, Tolvaptan, and Nephrolithiasis Risk
Ewout J. Hoorn and Robert Zietse

CJASN July 2020, 15 (7) 923-925; DOI: https://doi.org/10.2215/CJN.07610520

Add to Selected Citations
You have accessRestricted Access
A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials
Susan E. Shoaf, John Ouyang, Olga Sergeyeva, Alvin Estilo, Hui Li and Deborah Leung

CJASN May 2020, 15 (5) 643-650; DOI: https://doi.org/10.2215/CJN.08170719

Add to Selected Citations

Main menu

User menu

Search

polycystic kidney disease

Pages

Articles

Information for Authors

About

Journal Information

More Information